CYP 2.33% 21.0¢ cynata therapeutics limited

Phase 1 interim results imminent, page-92

  1. 569 Posts.
    lightbulb Created with Sketch. 130
    Steroid-resistant GVHD can still be treated by other more 'conventional' medications that we have decades of experience with so I presume many patients are still opting for this rather than the stem cells.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.